S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
MarketsFN
Home/Hedge Fund/RTW Investments/Q2 2026

RTW Investments

Periodo: Q2 2026 · Depositato: 2026-08-14
Vedi su SEC EDGAR
AUM
$11.71B
Valore totale del portafoglio
Posizioni
84
Titoli dichiarati
Prima Posizione
MDGL
9.1% $1.07B
Var. Trimestrali
+8 / -8
nuovi · usciti
⚠️Informativa sui Depositi 13F

I dati AUM mostrati sono calcolati sommando il valore di mercato dichiarato di tutte le posizioni nei depositi SEC 13F-HR — non rappresentano il patrimonio effettivo gestito dal fondo.

  • Escluse liquidità, obbligazioni, private equity, posizioni corte e azioni estere non soggette all'obbligo di dichiarazione.
  • Per le opzioni PUT e CALL, il Valore dichiarato è il valore nozionale delle azioni sottostanti — non il premio pagato. Ciò sovrastima significativamente il capitale effettivamente a rischio.
  • Il patrimonio reale del fondo è tipicamente superiore e include strategie, strumenti e posizioni che non compaiono mai in un 13F.
  • I depositi 13F riguardano i gestori istituzionali con ≥$100M in titoli 13F. Le posizioni riflettono le partecipazioni a fine trimestre, divulgate entro 45 giorni dalla fine del periodo.

Dati provenienti da SEC EDGAR. Questo tracker è a scopo puramente informativo e non costituisce consulenza finanziaria.

Partecipazioni in Portafoglio

Prime 30 posizioni

⚠️ Performance % calcolata dalla data di deposito ( 2026-08-14) si riferisce al titolo sottostante — non al P&L del derivato.
TickerEmittenteNozionalePortafoglio %Al DepositoOra (Fine Giornata)Dal DepositoAllocazione
MDGLMADRIGAL PHARMACEUTICALS INC$1.07B9.14%$536.95$507.56-5.5%
9.1%
ARGXARGENX SE$658.2M5.62%$927.77$851.29-8.2%
5.6%
PTCTPTC THERAPEUTICS INC$631.9M5.39%$81.57$71.70-12.1%
5.4%
PTGXPROTAGONIST THERAPEUTICS INC$620.4M5.30%$122.58$155.10+26.5%
5.3%
CGONCG ONCOLOGY INC$605.0M5.16%$71.05$75.03+5.6%
5.2%
INSMINSMED INC$516.4M4.41%$106.62$123.74+16.1%
4.4%
TNGXTANGO THERAPEUTICS INC$434.5M3.71%$31.26$25.60-18.1%
3.7%
SYRESPYRE THERAPEUTICS INC$377.5M3.22%$88.78$103.63+16.7%
3.2%
CELCCELCUITY INC$345.8M2.95%$104.62$92.00-12.1%
3.0%
ERASERASCA INC$328.8M2.81%$18.32$18.38+0.3%
2.8%
RDNTRADNET INC$298.9M2.55%$61.67$76.35+23.8%
2.5%
ORKAORUKA THERAPEUTICS INC$298.7M2.55%$95.17$111.04+16.7%
2.5%
NTRANATERA INC$271.4M2.32%$271.45$309.93+14.2%
2.3%
RAREULTRAGENYX PHARMACEUTICAL IN$260.3M2.22%$33.39$26.49-20.7%
2.2%
IRTCIRHYTHM HOLDINGS INC$259.6M2.22%$118.95$126.44+6.3%
2.2%
CYTKCYTOKINETICS INC$243.8M2.08%$85.19$74.13-13.0%
2.1%
KLRAKAILERA THERAPEUTICS INC$237.4M2.03%$22.03$17.94-18.6%
2.0%
ESTAESTABLISHMENT LABS HLDGS INC$227.9M1.95%$85.81$79.47-7.4%
1.9%
GHGUARDANT HEALTH INC$222.2M1.90%$150.03$157.21+4.8%
1.9%
NBIXNEUROCRINE BIOSCIENCES INC$213.7M1.82%$168.54$152.72-9.4%
1.8%
TARSTARSUS PHARMACEUTICALS INC$211.3M1.80%$62.94$69.20+9.9%
1.8%
STOKSTOKE THERAPEUTICS INC$184.0M1.57%$32.72$31.27-4.4%
1.6%
QUREUNIQURE NV$181.6M1.55%$46.06$48.62+5.6%
1.6%
ACADACADIA PHARMACEUTICALS INC$180.8M1.54%$25.30$28.24+11.6%
1.5%
RGENREPLIGEN CORP$169.3M1.45%$136.44$166.83+22.3%
1.4%
URGNUROGEN PHARMA LTD$167.2M1.43%$36.80$48.22+31.0%
1.4%
GHRSGH RESEARCH PLC$159.5M1.36%$26.88$29.49+9.7%
1.4%
IMCRIMMUNOCORE HLDGS PLC$154.6M1.32%$31.75$34.21+7.8%
1.3%
CMPSCOMPASS PATHWAYS PLC$151.4M1.29%$14.15$13.45-5.0%
1.3%
IMTXIMMATICS N.V$131.1M1.12%$10.13$9.44-6.8%
1.1%

Attività Trimestre su Trimestre

Q2 2026 vs. Q1 2026

Nuove Posizioni (8)

TickerEmittenteNozionaleDal Deposito
KLRAKAILERA THERAPEUTICS INC$237.4M-18.6%
GPCRSTRUCTURE THERAPEUTICS INC$86.3M
AXGNAXOGEN INC$46.7M
DHRDANAHER CORP DEL$43.8M
SLDBSOLID BIOSCIENCES INC$38.9M
IDYAIDEAYA BIOSCIENCES INC$13.8M
ALLOALLOGENE THERAPEUTICS INC$6.8M
MAZEMAZE THERAPEUTICS INC$6.3M

Posizioni Chiuse (8)

TickerEmittenteNozionale
APGEAPOGEE THERAPEUTICS INC$234.2M
APLSAPELLIS PHARMACEUTICALS INC$148.3M
ISRGINTUITIVE SURGICAL INC$101.4M
CNTACENTESSA PHARMACEUTICALS PLC$81.6M
CRNXCRINETICS PHARMACEUTICALS IN$52.7M
WAYWAYSTAR HLDG CORP$39.3M
ARWRARROWHEAD PHARMACEUTICALS IN$36.7M
SYKSTRYKER CORPORATION$32.9M

Aumentate (8)

TickerEmittenteNozionaleVar. AzioniDal Deposito
RAREULTRAGENYX PHARMACEUTICAL IN$183.9M+113.7%-20.7%
TENXTENAX THERAPEUTICS INC$4.2M+88.1%
LRMRLARIMAR THERAPEUTICS INC$1.1M+71.1%
ORKAORUKA THERAPEUTICS INC$197.8M+52.5%+16.7%
QUREUNIQURE NV$139.3M+52.4%+5.6%
CGEMCULLINAN THERAPEUTICS INC$18.8M+38.6%
DFTXDEFINIUM THERAPEUTICS INC$13.2M+33.3%
IRTCIRHYTHM HOLDINGS INC$62.7M+30.8%+6.3%

Ridotte (8)

TickerEmittenteNozionaleVar. AzioniDal Deposito
AVTXAVALO THERAPEUTICS INC$-9.6M-79.6%
HNGEHINGE HEALTH INC$-32.9M-74.1%
COGTCOGENT BIOSCIENCES INC$-120.8M-57.7%
XGNEXAGEN INC$-0.3M-50.7%
HTFLHEARTFLOW INC$-3.4M-40.4%
BBNXBETA BIONICS INC$3.5M-25.0%
NTRANATERA INC$21.5M-20.0%+14.2%
TSHATAYSHA GENE THERAPIES INC$31.2M-0.9%
Torna agli Hedge Fund